China Implements New Quality System To Strengthen Drug Safety; Puts Legal Onus On Drug Quality Attorneys
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - China's State FDA launched a new quality system April 10 that requires companies to assign responsibility for drug manufacturing to a drug quality administrator. The move builds accountability into drug manufacturers' systems